Q1 2023 Non-GAAP Operating Income
2023 Non-GAAP Outlook
| 27 |
**
$ billions, except EPS or as noted
2023 Outlook
Revenues*
COPAXONE ($m)*
AUSTEDO ($m)*
$14.8 - $15.4
~500
2022 Actual
$14.9
691
~1,200
971
~400
377
4.0-4.4
4.1
4.5-4.9
4.6
~1,000
904
AJOVY ($m)*
Operating Income
Adjusted EBITDA
Finance Expenses ($m)
Tax Rate
14% -17%
Diluted EPS ($)
Free Cash Flow*
CAPEX*
**
Foreign Exchange
11.7%
2.25 -2.55
1,123 million shares
2.52
1,115 million shares
1.7-2.1
2.2
0.5
0.5
Volatile swings in FX can negatively impact revenue and income
Revenues and CAPEX are presented on a GAAP basis
Free Cash Flow includes cash flow generated from operating activities net of capital expenditures and deferred purchase price cash component collected for securitized trade receivables
tevaView entire presentation